Happening TODAY!
See how Takeda is scaling AI across R&D, in our upcoming live webinar.
ai platform
AI PLATFORM
Generative AI Copilot

The first AI copilot purpose-built for scientists

Knowledge Graph

High-precision biomedical knowledge graph

Enterprise Data Fabric

Get more from your data

Scientific Information Retrieval System (SIRS)

Information retrieval for life sciences AI

Mitigating clinical failures with AI

Overcoming the Toxicity Hurdle in Clinical Development

Scientists from big pharma are incorporating AI into their R&D processes to identify potential safety red flags earlier on in the development pipeline.

Request access
products
products
Scientific Workflows

Turn scientific expertise to scalable execution

Agentic Research

Science-grade AI for R&D

Discover

Enable your research workforce at scale

Bio Graph

More access, more knowledge

Bio Graph API

Bring the most powerful life sciences knowledge graph in-house

Pipeline Graph

Competitive intelligence meets scientific research

Mitigating clinical failures with AI

Overcoming the Toxicity Hurdle in Clinical Development

Scientists from big pharma are incorporating AI into their R&D processes to identify potential safety red flags earlier on in the development pipeline.

Request access
Use cases
Use cases
Target Identification & Prioritization

Rapidly identify and prioritize targets

Biomarker Discovery

Revolutionize biomarker research

Disease Pathophysiology

Decipher complex disease biology

Target Disease Association

Connect targets and diseases with confidence

Indication Expansion

Unlock new revenue growth from existing assets

Mitigating clinical failures with AI

Overcoming the Toxicity Hurdle in Clinical Development

Scientists from big pharma are incorporating AI into their R&D processes to identify potential safety red flags earlier on in the development pipeline.

Request access
Solutions
Solutions
Target Product Profile

Build a Target Product Profile every function can act on

Mitigating clinical failures with AI

Overcoming the Toxicity Hurdle in Clinical Development

Scientists from big pharma are incorporating AI into their R&D processes to identify potential safety red flags earlier on in the development pipeline.

Request access
Partners
Resources
Resources
All Resources

Discover our latest resources.

Blog

Discover the latest reports, data sheets, articles, infographics, and videos on biomedical R&D and AI.

News

The latest news and updates from Causaly.

Events and Webinars

Our events and webinars on demand and dig deeper into the next era of scientific research.

Case Studies

Read our latest case studies and see how we’ve helped our customers.

Downloads

The latest downloadable content from Causaly.

Featured

From the Lab’s Biggest AI Skeptic to Its Advocate

Jessica Armand spent five years studying drug resistance in breast cancer and told everyone in her lab not to trust AI. Now she's an AI advocate and onboards skeptical scientists onto the...

Read more
About
loginRequest a demo
AI Platform
Generative AI CopilotKnowledge GraphEnterprise Data FabricScientific RAG
Products
Scientific WorkflowsAgentic ResearchDiscoverBio GraphBio Graph APIPipeline Graph
Use cases
Target Identification & PrioritizationBiomarker DiscoveryDisease PathophysiologyTarget Disease AssociationIndication Expansion
Solutions
Target Product Profile
Partners
Resources
All ResourcesBlogNewsEvents and WebinarsCase StudiesDownloads
ABOUTLOGINrEQUEST A DEMO

Case studies

Read our latest case studies and see how we’ve helped our customers.

Featured Case Studies

Case studies

Eisai & Causaly: From fragmented search to scientific intelligence, embedded in every team

June 24, 2026
Read more
Case studies

ProQR Uses Causaly to Support Target Identification For Axiomer™ Platform

ProQR
February 28, 2025
Read more

All Case Studies

Case studies

Eisai & Causaly: From fragmented search to scientific intelligence, embedded in every team

June 24, 2026
Read more
Case studies

How Causaly Cut Proposal Time by 75% During a Critical Disease Area Transition

Top 10 Global Life Sciences Company
April 30, 2026
Read more
Case studies

How Manas AI uses Causaly to validate targets and reduce early-stage risk

April 2, 2026
Read more
Case studies

How a Top 10 Pharma Company Transformed Clinical Program Evaluation with Causaly

Top 10 Pharma
March 25, 2026
Read more
Case studies

How a scientist accelerates target validation with Causaly

Top 50 Pharma
February 20, 2026
Read more
Case studies

Using Causaly to Accelerate Clinical Evidence Validation for FDA Submissions

Top 50 Pharma
January 7, 2026
Read more
Causaly logo

Unlock scientific insights from external and internal information at unprecedented levels of precision and efficiency.

Get started
Login
Causaly
AboutRequest a demoContact usResourcesCareers
LEGAL
Privacy policy
Terms of service
Cookies settings
© Causaly. All rights reserved.